Hess JR, Greenwalt TG
171 The development of small molecule GLP-1RAs aims to overcome some of the limitations of traditional protein or peptide-based GLP-1RAs, such as the need for injection
Vitamin B12 deficiency is common in people with Hashimotos disease
09/17/2025|5 minute read Featured Insights News Julian Perlman Appointed as Chair of Exemptions and Immunities Committee of ABA Antitrust Section for Second Consecutive Year 07/24/2026|1 minute read News Katherine Lowry Shares Legal AI Insights in Bloomberg Law Article 07/24/2026|1 minute read Speaking Engagement James Sherer Participates in Bridge-the-Gap II: Ethics and Skills for Newly Admitted New York Attorneys 2026 07/24/2026|1 minute read IP Intelligence Report As Ex Parte Reexamination Requests Rise, the USPTO Expands Its Threshold Review 07/23/2026|4 minute read See All Insights
HRP Conjugate Stabilizer, Non-Mammalian-based, 1X (formerly Neptune HRP Conjugate Stabilizer) preserves the activity of concentrated and diluted IgG-HRP conjugates in traditional antigen-down or antibody sandwich ELISA formats
There are other important secondary outcomes, including the change in logMAR visual acuity, the development of center-involved diabetic macular edema (CI-DME) and the development of retinopathy, macular edema or vitreous hemorrhage requiring treatment
:format(webp))
